Cerner (CERN) Tops Q2 EPS by 1c; Guides In-Line

Cerner (NASDAQ: CERN) reported Q2 EPS of $0.58, $0.01 better than the analyst estimate of $0.57. Revenue for the quarter came in at $1.22 billion versus the consensus estimate of $1.21 billion.

“Cerner’s strong second quarter results reflect good execution and competitiveness in the U.S. and abroad,” said Zane Burke, Cerner President. “We continued to gain share in what remains an active Electronic Health Record replacement market, while also having strong sales of revenue cycle and population health solutions that help our clients navigate the rapidly evolving reimbursement landscape.”

GUIDANCE:

Cerner sees Q3 2016 EPS of $0.59-$0.61, versus the consensus of $0.61. Cerner sees Q3 2016 revenue of $1.2-1.275 billion, versus the consensus of $1.26 billion.

Cerner sees FY2016 EPS of $2.30-$2.40, versus the consensus of $2.35.

For earnings history and earnings-related data on Cerner (CERN) click here.

You May Also Be Interested In

• AbbVie updates 2026 EPS guidance after $291M IPR&D charge
• Intercontinental Exchange (ICE) PT Lowered to $208 at Raymond James, 'we view the risk/reward as attractive'
• Vertex to acquire Crinetics Pharmaceuticals for $10 billion